NCT03953768View on ClinicalTrials.gov

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

December 13, 2025

Study Completion Date

December 31, 2026

Conditions
Autoimmune DiseasesEpilepsyAutonomic DysfunctionInflammatory Bowel Diseases
Interventions
DEVICE

Vagal nerve stimulation (VNS)

Implantation with vagal nerve stimulator for epilepsy

Trial Locations (4)

40202

NOT_YET_RECRUITING

Norton Healthcare, Louisville

RECRUITING

University of Louisville, Louisville

77030

ACTIVE_NOT_RECRUITING

Texas Children's Hospital, Houston

84113

RECRUITING

Primary Children's Hospital/University of Utah, Salt Lake City

Sponsors

Collaborators (1)

LivaNova
All Listed Sponsors
collaborator

LivaNova

INDUSTRY

collaborator

Norton Foundation

UNKNOWN

lead

University of Louisville

OTHER